Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study)

• Abeer M Shaaban,
• Karoline Freeman,
• Sian Taylor-Phillips,
• Nisha Sharma,
• Olive Kearins,
• Cliona Kirwan,
• Karen Clements,
• Nigel Stallard,
• Alastair M Thompson,
• David Jenkinson,
• Hilary Stobart,
• Sarah Pinder,
• Elena Provenzano,
• Matthew G Wallis,
• Bridget Hilton,
• Joanne Dulson-Cox,
• Samantha McDonnell

Affiliations

Abeer M Shaaban

1 Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK

Karoline Freeman

senior research fellow

Sian Taylor-Phillips

Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK

Nisha Sharma

Breast Unit, St James’s Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Olive Kearins

7 National Lead Breast Screening QA, Public Health England, Birmingham, UK

Cliona Kirwan

Department of Surgery, The University of Manchester, Manchester, UK

Karen Clements

project manager

Nigel Stallard

1 Warwick Medical School, University of Warwick, Coventry, UK

Alastair M Thompson

professor of surgery

David Jenkinson

Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK

Hilary Stobart

5Patient Representative, Birmingham, UK

Sarah Pinder

Department of Histopathology, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK

Elena Provenzano

10 NIHR Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK

Matthew G Wallis

clinical director

Bridget Hilton

Screening Quality Assurance Services, NHS England and NHS Improvement, Birmingham, UK

Joanne Dulson-Cox

Screening Quality Assurance Services, NHS England and NHS Improvement, Birmingham, UK

Samantha McDonnell

Warwick Medical School, University of Warwick, Coventry, UK